SBI Securities’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

SBI Securities’s Portfolio RVPH Stock Details RVPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-250	Closed	-$182	–	4170
2026 Q1	$182	Hold	250	–	–	﹤0.01%	3254
2025 Q4	$1.4K	Hold	250	–	–	﹤0.01%	2518
2025 Q3	$1.84K	Sell	250 -1	-0.4%	-$8	﹤0.01%	2453
2025 Q2	$1.91K	Buy	+251	New	+$3.91K	﹤0.01%	2403

Other funds holding RVPH

ECM

EMC Capital Management Houston, Texas $253M AUM

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

PUI

Purpose Unlimited Inc Toronto $2.62B AUM

MGI

Miller Global Investments Dallas, Texas $121M AUM

MWM

Mosley Wealth Management Anaheim, California $314M AUM

SBI Securities's RVPH Position: Q2 2026 in Review

SBI Securities sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q2 2026, closing a stake of 250 shares — an estimated $182 sold.

SBI Securities first reported a position in RVPH in Q2 2025 and held it in 4 quarters. The position peaked at $1.91K in Q2 2025. 5 funds tracked by Wall St. Rank hold RVPH as of Q2 2026.

SBI Securities reported no remaining REVIVA PHARMA HLDGS INC position as of Q2 2026 after selling out during the quarter.
SBI Securities sold 250 REVIVA PHARMA HLDGS INC shares in Q2 2026, an estimated $182.
SBI Securities first reported a position in REVIVA PHARMA HLDGS INC in Q2 2025 and held it in 4 quarters.
SBI Securities's REVIVA PHARMA HLDGS INC position peaked at $1.91K in Q2 2025.
5 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.